CD8A and neoplasm: In macrophages, GC treatment was shown to promote genes involved in the tricarboxylic acid (TCA) cycle but inhibit glycolysis by suppressing hypoxia-inducible factor 1-alpha (HIF1α); however, how this impacted anti-tumor CD8+ T cell responses was not investigated [24].